Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103 conventional dendritic cells
/in Dendritic Cells, International PublicationsDendritic cell therapy in cancer treatment; the state-of-the-art
/in Dendritic Cells, International PublicationsDendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer
/in Dendritic Cells, International Publications, Pancreatic CancerDendritic Cells and Immunogenic Cancer Cell Death: A Combination for Improving Antitumor Immunity
/in Dendritic Cells, Hyperthermia, International PublicationsEmerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading?
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, Malignant Pleural MesotheliomaNew Insights into Mechanisms of Long-term Protective Anti-tumor Immunity Induced by Cancer Vaccines Modified by Virus Infection
/in Dendritic Cells, International Publications, IOZK Veröffentlichungen, Newcastle Disease VirusDendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting
/in Dendritic Cells, International PublicationsDendritic cell vaccine for the effective immunotherapy of breast cancer
/in Breast Cancer, Dendritic Cells, International PublicationsToll-like receptor 7/8-matured RNA-transduced dendritic cells as post-remission therapy in acute myeloid leukaemia: results of a phase I trial
/in Acute Leukemia, Dendritic Cells, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer